» Articles » PMID: 18594795

Discriminative Stimulus Properties of Naloxone in Long-Evans Rats: Assessment with the Conditioned Taste Aversion Baseline of Drug Discrimination Learning

Overview
Specialty Pharmacology
Date 2008 Jul 3
PMID 18594795
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: The characterization of the discriminative stimulus properties of naloxone has focused primarily on its actions at the mu opioid receptor, although naloxone also displays an affinity for delta and kappa receptor subtypes.

Objectives: The present study extends this characterization of the naloxone cue by investigating if relatively specific antagonists for the mu (naltrexone: 0.10-0.56 mg/kg), delta (naltrindole: 1-18 mg/kg), and kappa (MR2266: 1.8-10 mg/kg) opioid receptor subtypes will substitute for naloxone in animals trained to discriminate naloxone from its vehicle. The temporal nature of the naloxone cue was examined by varying pretreatment time points (15, 30, 45, 60 min). Finally, various doses of naltrexone methobromide (1-18 mg/kg) were assessed to determine peripheral mediation of the cue.

Materials And Methods: Female Long-Evans rats (N = 30) received an injection of naloxone (1 mg/kg; i.p.) 15 min prior to a pairing of saccharin (20-min access) and the emetic LiCl (1.8 mEq; i.p.; n = 16, group NL) or vehicle (n = 14, group NW); on other days, they were injected with saline prior to saccharin alone. Substitution tests with compounds with various receptor affinities and selective CNS and PNS actions were then assessed.

Results: Only naloxone and naltrexone produced dose-dependent decreases in saccharin consumption. Naloxone administered at 15 and 30 min before saccharin produced decreases in consumption similar to that displayed on training days. Naltrexone methobromide substituted only at the highest dose tested (18 mg/kg).

Conclusions: Naloxone's stimulus effects appear to be mediated centrally via activity at the mu opioid receptor.

Citing Articles

Modulation of time in Parkinson's disease: a review and perspective on cognitive rehabilitation.

Honma M, Terao Y Front Psychiatry. 2024; 15:1379496.

PMID: 38686125 PMC: 11056500. DOI: 10.3389/fpsyt.2024.1379496.


Conditioned Taste Avoidance Drug Discrimination Procedure: Assessments and Applications.

Riley A, Clasen M, Friar M Curr Top Behav Neurosci. 2016; 39:297-317.

PMID: 27221624 DOI: 10.1007/7854_2016_8.


Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.

Bojanowska E, Ciosek J Curr Neuropharmacol. 2015; 14(2):118-42.

PMID: 26549651 PMC: 4825944. DOI: 10.2174/1570159x14666151109103147.


Recent progress in perceptual learning research.

Sasaki Y, Nanez J, Watanabe T Wiley Interdiscip Rev Cogn Sci. 2013; 3(3):293-299.

PMID: 24179564 PMC: 3811035. DOI: 10.1002/wcs.1175.


Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.

Jarbe T, LeMay B, Vemuri V, Vadivel S, Zvonok A, Makriyannis A Psychopharmacology (Berl). 2011; 216(3):355-65.

PMID: 21369753 PMC: 3727221. DOI: 10.1007/s00213-011-2226-3.

References
1.
Valentino R, Herling S, Woods J . Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons. J Pharmacol Exp Ther. 1983; 224(2):307-13. View

2.
Koob G, Pettit H, Ettenberg A, Bloom F . Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J Pharmacol Exp Ther. 1984; 229(2):481-6. View

3.
Smurthwaite S, Kautz M, Geter B, Riley A . Naloxone as a stimulus in drug discrimination learning: generalization to other opiate antagonists. Pharmacol Biochem Behav. 1992; 41(1):43-7. DOI: 10.1016/0091-3057(92)90056-l. View

4.
Sell S, McMahon L, France C . Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone. J Pharmacol Exp Ther. 2003; 306(3):1167-73. DOI: 10.1124/jpet.103.051425. View

5.
White D, Hwang M, Holtzman S . Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. Pharmacol Biochem Behav. 2005; 81(3):451-8. DOI: 10.1016/j.pbb.2005.04.002. View